Pro-Dex Valuation Multiples

Pro-Dex is valued at $201M as of October 2026, a 2.7x revenue multiple. In the last 12 months, Pro-Dex revenue was $79M and Pro-Dex EBITDA was $15M.

Pro-Dex Overview

About Pro-Dex

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.


Founded

1994

HQ

United States

Employees

181

Financials (LTM)

Revenue: $79M
EBITDA: $15M

EV

$210M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pro-Dex Financials

Pro-Dex reported last 12-month revenue of $79M and EBITDA of $15M.

In the same LTM period, Pro-Dex generated $25M in gross profit, $15M in EBITDA, and $13M in net income.

Revenue (LTM)


Pro-Dex P&L

In the most recent fiscal year, Pro-Dex reported revenue of $78M and EBITDA of $20M.

Pro-Dex is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 26%, and net margin of 18%.

See analyst estimates for Pro-Dex
LTMLast FY202320242025202620272028
Revenue$79M$78M$50M$60M$78M
Gross Profit$25M$24M$14M$17M$24M
Gross Margin32%31%27%28%31%
EBITDA$15M$20M$8M$9M$15M
EBITDA Margin19%26%15%15%19%
EBIT Margin17%17%13%15%17%
Net Profit$13M$14M$5M$6M$14M
Net Margin16%18%9%9%18%
Net Debt-$10M---

Financial data powered by Morningstar, Inc.

Pro-Dex Stock Performance

Pro-Dex has current market cap of $201M, and enterprise value of $210M.

Market Cap Evolution


Pro-Dex's stock price is $62.12.

Pro-Dex share price decreased by 9.8% in the last 30 days, and increased by 71.4% in the last year.

Pro-Dex has an EPS (earnings per share) of $4.23.

See more trading valuation data for Pro-Dex
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$210M$201M2.3%-9.8%6.1%71.4%$4.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pro-Dex Valuation Multiples

Pro-Dex trades at 2.7x EV/Revenue multiple, and 13.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Pro-Dex

EV / Revenue (LTM)


Pro-Dex Financial Valuation Multiples

As of October 23, 2026, Pro-Dex has market cap of $201M and EV of $210M.

Pro-Dex has a P/E ratio of 15.8x.

LTMLast FY202320242025202620272028
EV/Revenue2.7x2.7x4.2x3.5x2.7x
EV/EBITDA13.9x10.5x27.7x22.8x14.0x
EV/EBIT15.8x16.2x32.5x23.6x16.2x
EV/Gross Profit8.3x8.6x15.4x12.4x8.6x
P/E15.8x14.7x43.7x36.2x14.7x
EV/FCF-31.1x43.4x184.0x(71.9x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pro-Dex Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pro-Dex Margins & Growth Rates

Pro-Dex grew revenue by 7% but EBITDA decreased by 23% in the last fiscal year.

In the most recent fiscal year, Pro-Dex reported gross margin of 31%, EBITDA margin of 26%, and net margin of 18%.

See estimated margins and future growth rates for Pro-Dex

Pro-Dex Margins

Last FY202420252026202720282029
Gross Margin31%28%31%32%
EBITDA Margin26%15%19%22%
EBIT Margin17%15%17%17%
Net Margin18%9%18%15%
FCF Margin9%2%(4%)-

Pro-Dex Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%21%29%3%
Gross Profit Growth14%25%43%7%
EBITDA Growth(23%)22%62%18%
EBIT Growth8%38%46%4%
Net Profit Growth(22%)21%146%(11%)
FCF Growth-(76%)(356%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Pro-Dex Operational KPIs

Pro-Dex's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Pro-Dex's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pro-Dex's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Pro-Dex
LTMLast FY202320242025202620272028
Rule of 4025%25%---
Bessemer Rule of X34%30%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue0%1%0%0%0%
G&A Expenses to Revenue10%10%8%7%10%
R&D Expenses to Revenue5%4%6%6%4%
Opex to Revenue-15%14%13%11%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pro-Dex Competitors

Pro-Dex competitors include Edap TMS, Tess Holdings Co, Profound Medical, RxSight, Inogen, AOTI, SmartVest, TriSalus Life Sciences, BICO Group and Median Technologies.

Most Pro-Dex public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Edap TMS$71M($25M)3.1x3.9x(8.7x)(6.9x)
Tess Holdings Co$325M$78M2.1x2.0x8.7x-
Profound Medical$16M($43M)11.1x7.5x(4.2x)(5.8x)
RxSight$134M($45M)0.1x0.1x(0.3x)(0.3x)
Inogen$349M($7M)0.3x0.3x(13.6x)26.1x
AOTI$67M$8M2.9x2.7x25.5x27.7x
SmartVest$74M$15M2.7x2.6x13.5x11.2x
TriSalus Life Sciences$45M($34M)4.7x4.1x(6.3x)(11.9x)

This data is available for Pro users. Sign up to see all Pro-Dex competitors and their valuation data.

Start Free Trial

Acquisitions by Pro-Dex

Pro-Dex has acquired 1 company to date.

Last acquisition by Pro-Dex was on February 12th 2026. Pro-Dex acquired Advanced Precision Machining for $9M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Pro-Dex

Advanced Precision Machining
Description
Advanced Precision Machining produces custom precision components through machining and fabrication processes. The company caters to aerospace, defense, and medical sectors with high-tolerance parts from its US facilities.
HQ CountryUnited States
HQ City
-
Deal Date12 Feb 2026
Valuation$9M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Pro-Dex acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pro-Dex

Who are competitors of Pro-Dex?Pro-Dex main competitors include Edap TMS, Tess Holdings Co, Profound Medical, RxSight, Inogen, AOTI, SmartVest, TriSalus Life Sciences, BICO Group, Median Technologies.

See public comps similar to Pro-Dex

Lists including Pro-Dex

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial